Vitamin C may have adverse effects in ICU patients after cardiac arrest
Overview
A recent trial found that high-dose vitamin C may worsen organ dysfunction in ICU patients following out-of-hospital cardiac arrest. The study indicated a significant increase in adverse outcomes, particularly in the group receiving 10 g of vitamin C daily.
Background
The potential benefits of vitamin C in critical illness have been debated, particularly regarding its antioxidant properties and ability to mitigate organ dysfunction after cardiac arrest. However, previous studies in sepsis have raised concerns about the safety of high-dose vitamin C, suggesting that it may lead to worse outcomes.
Data Highlights
Group
SOFA Score Change
Kidney Replacement Therapy
ICU-Acquired Weakness
10 g Vitamin C
-2.5
10%
29%
3 g Vitamin C
-0.9
N/A
N/A
Placebo
N/A
1%
18%
Key Findings
Organ dysfunction worsened in the 10 g vitamin C group compared to placebo.
The 3 g vitamin C group showed a smaller increase in organ dysfunction.
Higher doses of vitamin C were associated with increased need for kidney replacement therapy.
Patients receiving high-dose vitamin C developed ICU-acquired weakness more frequently.
Biomarker analyses indicated higher troponin concentrations in the 10 g group.
Overall patient-centered outcomes were less favorable with vitamin C treatment.
Clinical Implications
The findings indicate potential harm in patients following out-of-hospital cardiac arrest.
Conclusion
The study's results indicate that vitamin C, especially in the doses tested, may not be beneficial after out-of-hospital cardiac arrest.